MENU
MET
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

MET stock forecast, quote, news & analysis

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
MET
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for MET with price predictions
Oct 13, 2026

MET in +2.36% Uptrend, growing for three consecutive days on October 13, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 44 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 31 of 52 cases over the following month. The odds of a continued upward trend are 60%.

MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.219) is slightly higher than the industry average of (1.355). P/E Ratio (18.356) is within average values for comparable stocks, (20.332). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.037) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

MET paid dividends on September 08, 2026

MetLife MET Stock Dividends
А dividend of $0.59 per share was paid with a record date of September 08, 2026, and an ex-dividend date of August 04, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are MetLife (NYSE:MET), Prudential Financial (NYSE:PRU), Lincoln National Corp (NYSE:LNC), Genworth Financial (NYSE:GNW).

Industry description

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Life/Health Insurance Industry is 18.26B. The market cap for tickers in the group ranges from 228.36K to 140.68B. CILJF holds the highest valuation in this group at 140.68B. The lowest valued company is GWGHQ at 228.36K.

High and low price notable news

The average weekly price growth across all stocks in the Life/Health Insurance Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -3%. MET experienced the highest price growth at 4%, while AAME experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Life/Health Insurance Industry was -23%. For the same stocks of the Industry, the average monthly volume growth was -3% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 71
Price Growth Rating: 58
SMR Rating: 91
Profit Risk Rating: 60
Seasonality Score: 33 (-100 ... +100)
View a ticker or compare two or three
MET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of insurance and financial services and also function as bank holding company

Industry LifeHealthInsurance

Industry
Life Or Health Insurance
Address
200 Park Avenue
Phone
+1 212 578-9500
Employees
46000
Web
https://www.metlife.com
MET in +2.36% Uptrend, growing for three consecutive days on October 13, 2026